Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Idera Pharmaceuticals Inc (NASDAQ:IDRA)

2.79
Delayed Data
As of Sep 01
 -0.23 / -7.62%
Today’s Change
1.94
Today|||52-Week Range
5.48
-36.73%
Year-to-Date

Today’s Trading

Previous close3.02
Today’s open2.95
Day’s range2.75 - 2.98
Volume1,579,819
Average volume (3 months)1,660,424
Market cap$356.7M
Dividend yield--
Data as of 3:59pm ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)+2.08%
Earnings growth (this year)+2.84%
Earnings growth (next 5 years)--
Revenue growth (last year)+55.32%
P/E ratioNM
Price/Sales5,003.66
Price/Book6.60

Competitors

 Today’s
change
Today’s
% change
OREXOrexigen Therapeutic...-0.09-3.25%
ZGNXZogenix Inc-0.74-3.85%
ADMSAdamas Pharmaceutica...-0.48-2.39%
LIFEaTyr Pharma Inc-0.40-2.76%
Data as of 3:59pm ET, 09/01/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$73.0K
Annual profit (last year)-$38.6M
Net profit margin-52,934.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vincent J. Milano
CFO, Treasurer &
Senior Vice President-Operations
Louis J. Arcudi
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers